 Analgesics, Opioid
"Analgesics, Opioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.
| Descriptor ID |
D000701
|
| MeSH Number(s) |
D27.505.696.277.600.500 D27.505.696.663.850.014.760.500 D27.505.954.427.040.550.500 D27.505.954.427.210.600.500
|
| Concept/Terms |
Partial Opioid Agonists- Partial Opioid Agonists
- Agonists, Partial Opioid
- Opioid Agonists, Partial
- Opioid Partial Agonists
- Agonists, Opioid Partial
- Partial Agonists, Opioid
Full Opioid Agonists- Full Opioid Agonists
- Agonists, Full Opioid
- Opioid Agonists, Full
- Opioid Full Agonists
- Agonists, Opioid Full
- Full Agonists, Opioid
Opioid Mixed Agonist-Antagonists- Opioid Mixed Agonist-Antagonists
- Agonist-Antagonists, Opioid Mixed
- Mixed Agonist-Antagonists, Opioid
- Opioid Mixed Agonist Antagonists
|
Below are MeSH descriptors whose meaning is more general than "Analgesics, Opioid".
Below are MeSH descriptors whose meaning is more specific than "Analgesics, Opioid".
This graph shows the total number of publications written about "Analgesics, Opioid" by people in this website by year, and whether "Analgesics, Opioid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 3 | 1 | 4 | | 2000 | 2 | 4 | 6 | | 2001 | 2 | 3 | 5 | | 2002 | 4 | 2 | 6 | | 2003 | 1 | 2 | 3 | | 2004 | 3 | 1 | 4 | | 2005 | 3 | 1 | 4 | | 2006 | 6 | 1 | 7 | | 2007 | 8 | 2 | 10 | | 2008 | 4 | 4 | 8 | | 2009 | 7 | 3 | 10 | | 2010 | 10 | 1 | 11 | | 2011 | 9 | 5 | 14 | | 2012 | 9 | 5 | 14 | | 2013 | 10 | 6 | 16 | | 2014 | 14 | 3 | 17 | | 2015 | 15 | 6 | 21 | | 2016 | 21 | 6 | 27 | | 2017 | 28 | 6 | 34 | | 2018 | 32 | 15 | 47 | | 2019 | 26 | 15 | 41 | | 2020 | 32 | 17 | 49 | | 2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Analgesics, Opioid" by people in Profiles.
-
Casella JF, Barton BA, Kanter J, Black LV, Majumdar S, Inati A, Wali Y, Drachtman RA, Abboud MR, Kilinc Y, Fuh BR, Al-Khabori MK, Takemoto CM, Salman E, Sarnaik SA, Shah N, Morris CR, Keates-Baleeiro J, Raj A, Alvarez OA, Hsu LL, Thompson AA, Sisler IY, Pace BS, Noronha SA, Lasky JL, de Julian EC, Godder K, Thornburg CD, Kamberos NL, Nuss R, Marsh AM, Owen WC, Schaefer A, Tebbi CK, Chantrain CF, Cohen DE, Karakas Z, Piccone CM, George A, Fixler JM, Singleton TC, Moulton T, Quinn CT, de Castro Lobo CL, Almomen AM, Goyal-Khemka M, Maes P, Emanuele M, Gorney RT, Padgett CS, Parsley E, Kronsberg SS, Kato GJ, Gladwin MT. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA. 2021 04 20; 325(15):1513-1523.
-
Urman RD, Seger DL, Fiskio JM, Neville BA, Harry EM, Weiner SG, Lovelace B, Fain R, Cirillo J, Schnipper JL. The Burden of Opioid-Related Adverse Drug Events on Hospitalized Previously Opioid-Free Surgical Patients. J Patient Saf. 2021 03 01; 17(2):e76-e83.
-
Ibiloye EA, Barner JC, Lawson KA, Rascati KL, Evoy KE, Peckham AM. Prevalence of and Factors Associated with Gabapentinoid Use and Misuse Among Texas Medicaid Recipients. Clin Drug Investig. 2021 Mar; 41(3):245-253.
-
Geoffrey Severtson S, Kreider SED, Amioka EC, Margolin ZR, Iwanicki JL, Dart RC. Postmarketing Analysis of Misuse, Abuse, and Diversion of Xtampza ER. Pain Med. 2020 12 25; 21(12):3660-3668.
-
Cohen SP, Baber ZB, Buvanendran A, McLean BC, Chen Y, Hooten WM, Laker SR, Wasan AD, Kennedy DJ, Sandbrink F, King SA, Fowler IM, Stojanovic MP, Hayek SM, Phillips CR. Pain Management Best Practices from Multispecialty Organizations During the COVID-19 Pandemic and Public Health Crises. Pain Med. 2020 11 07; 21(7):1331-1346.
-
Frank JW, Carey E, Nolan C, Hale A, Nugent S, Krebs EE. Association Between Opioid Dose Reduction Against Patients' Wishes and Change in Pain Severity. J Gen Intern Med. 2020 12; 35(Suppl 3):910-917.
-
Frank JW, Bohnert ASB, Sandbrink F, McGuire M, Drexler K. Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety. J Gen Intern Med. 2020 12; 35(Suppl 3):983-987.
-
Iwanicki JL, Schwarz J, May KP, Black JC, Dart RC. Tramadol non-medical use in Four European countries: A comparative analysis. Drug Alcohol Depend. 2020 12 01; 217:108367.
-
Dripps IJ, Bertels Z, Moye LS, Tipton AF, Siegersma K, Baca SM, Kieffer BL, Pradhan AA. Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia. Sci Rep. 2020 10 19; 10(1):17629.
-
Slavova S, LaRochelle MR, Root ED, Feaster DJ, Villani J, Knott CE, Talbert J, Mack A, Crane D, Bernson D, Booth A, Walsh SL. Operationalizing and selecting outcome measures for the HEALing Communities Study. Drug Alcohol Depend. 2020 12 01; 217:108328.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|